Table of Content


1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market (Actual & Untapped) – Japan Proton Therapy (2009 – 2025)

4.1 Actual Proton Therapy Market
4.2 Untapped Proton Therapy Market



5. Number of Patients – Japan Proton Therapy (2009 – 2025)

5.1 Actual Numbers
5.2 Untapped Numbers



6. Cancer Types – Japan Proton Therapy Number of Patients (2009 – 2025)

6.1 Central Nervous System (CNS) Tumors
6.2 Head and Neck Cancer
6.3 Lung Cancer
6.4 GI (Gastro-Intestinal) Cancer
6.5 Hepatocellular Carcinoma (HCC) Cancer
6.6 Pancreas Cancer
6.7 Gynecologic Cancers
6.8 Prostate Cancer
6.9 Bone and Soft Tissue Cancer
6.10 Others Cancer



7. Cancer Types – Japan Proton Therapy Market (2009 – 2025)

7.1 Central Nervous System (CNS) Tumors
7.2 Head and Neck Cancer
7.3 Lung Cancer
7.4 GI (Gastro-Intestinal) Cancer
7.5 Hepatocellular Carcinoma (HCC) Cancer
7.6 Pancreas Cancer
7.7 Gynecologic Cancers
7.8 Prostate Cancer
7.9 Bone and Soft Tissue Cancer
7.10 Others Cancer



8. Japan – List of Proton Therapy Centers

8.1 Operating Proton Therapy Centers
8.2 Under-Construction Therapy Centers


9. By Centers – Number of Proton Therapy Patients Treated

9.1 Kashiwa (NCC) Proton Therapy Center (2008 – 2016)
9.2 Hyogo (HIBMC) Proton Therapy Center (2008 – 2016)
9.3 Tsukuba (PMRC, 2) Proton Therapy Center (2008 – 2016)
9.4 WERC Proton Therapy Center (2008 - 2009)
9.5 Shizuoka Proton Therapy Center (2008 – 2016)
9.6 Koriyama-City Proton Therapy Center (2008 – 2016)
9.7 Ibusuki (MMRI) Proton Therapy Center (2011 – 2016)
9.8 Fukui City (Prefectural Hospital) Proton Therapy Center (2013 – 2015)
9.9 Nagoya PTC, Nagoya, Aichi Proton Therapy Center (2013 – 2016)
9.10 Tosu (Saga-HIMAT) Proton Therapy Center (2013)
9.11 Nagano Proton Therapy Center (2014 - 2016)
9.12 Hokkaido Proton Therapy Center (2014 - 2016)


10. Reimbursement Policies – Japan Proton Therapy


11. Components of a Standard Proton Therapy Center

11.1 Type of Proton Accelerator

11.1.1 Synchrotrons (example: LLUMC at Loma Linda)
11.1.2 Cyclotrons (example: MGH Boston)
11.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
11.1.4 Linacs (Rome)
11.1.5 H-minus Synchrotrons
11.1.6 Separated Sector Cyclotrons
11.1.7 Super-conducting Cyclotrons
11.1.8 Fast Cycling Synchrotron

11.2 Beam Transport System
11.3 Beam Delivery System

11.3.1 The Passive Scattering Technique
11.3.2 Beam Scanning

11.4 Type of Nozzle

11.4.1 Single Scattering
11.4.2 Double Scattering
11.4.3 Uniform Scanning Nozzle
11.4.4 Pencil Scanning Nozzle

11.5 Treatment Planning System
11.6 Image Viewers
11.7 Patient Positioning System (PPS)
11.8 Human Resource


12. Company Analysis (2014 – 2025)

12.1 IBA Proton Therapy

12.1.1 Sales Analysis

12.2 Varian Medical Systems

12.2.1 Sales Analysis

12.3 Elekta

12.3.1 Sales Analysis



13. Proton Therapy – Driving Factors

13.1 Technology Advancement

13.1.1 Next-Generation Proton Technique

13.2 Growing Incidence of Cancer Patients in Japan


14. Challenges

14.1 Requires Huge Investment
14.2 Operation Challenges



List of Figures




Figure 2 1: Japan – Proton Therapy Market (Million US$), 2009 – 2018
Figure 2 2: Japan – Forecast for Proton Therapy Market (Million US$), 2019 – 2025
Figure 2 3: Japan – Untapped Proton Therapy Market (Million US$), 2009 – 2018
Figure 2 4: Japan – Forecast for Untapped Proton Therapy Market (Million US$), 2019 – 2025
Figure 3 1: Japan – Patient Treated with Proton Therapy (Number), 2009 – 2018
Figure 3 2: Japan – Forecast for Patient Treated with Proton Therapy (Number), 2019 – 2025
Figure 3 3: Japan – Untapped Patients for Proton Therapy (Number), 2009 – 2018
Figure 3 4: Japan – Forecast for Untapped Patients for Proton Therapy (Number), 2019 – 2025
Figure 4 1: Japan – Proton Therapy Patients by CNS (Number), 2009 – 2018
Figure 4 2: Japan – Forecast for Proton Therapy Patients by CNS (Number), 2019 – 2025
Figure 4 3: Japan – Proton Therapy Patients by Head and Neck (Number), 2009 – 2018
Figure 4 4: Japan – Forecast for Proton Therapy Patients by Head and Neck (Number), 2019 – 2025
Figure 4 5: Japan – Proton Therapy Patients by Lung Cancer (Number), 2009 – 2018
Figure 4 6: Japan – Forecast for Proton Therapy Patients by Lung Cancer (Number), 2019 – 2025
Figure 4 7: Japan – Proton Therapy Patients by GI Cancer (Number), 2009 – 2018
Figure 4 8: Japan – Forecast for Proton Therapy Patients by GI Cancer (Number), 2019 – 2025
Figure 4 9: Japan – Proton Therapy Patients by HCC (Number), 2009 – 2018
Figure 4 10: Japan – Forecast for Proton Therapy Patients by HCC (Number), 2019 – 2025
Figure 4 11: Japan – Proton Therapy Patients by Pancreas (Number), 2009 – 2018
Figure 4 12: Japan – Forecast for Proton Therapy Patients by Pancreas (Number), 2019 – 2025
Figure 4 13: Japan – Proton Therapy Patients by Gynecologic Cancer (Number), 2009 – 2018
Figure 4 14: Japan – Forecast for Proton Therapy Patients by Gynecologic Cancer (Number), 2019 – 2025
Figure 4 15: Japan – Proton Therapy Patients by Prostate Cancer (Number), 2009 – 2018
Figure 4 16: Japan – Forecast for Proton Therapy Patients by Prostate Cancer (Number), 2019 – 2025
Figure 4 17: Japan – Proton Therapy Patients by Bone and Soft Tissue (Number), 2009 – 2018
Figure 4 18: Japan – Forecast for Proton Therapy Patients by Bone and Soft Tissue (Number), 2019 – 2025
Figure 4 19: Japan – Proton Therapy Patients by Others (Number), 2009 – 2018
Figure 4 20: Japan – Forecast for Proton Therapy Patients by Others (Number), 2019 – 2025
Figure 5 1: Japan – Proton Therapy Market by CNS (Million US$), 2009 – 2018
Figure 5 2: Japan – Forecast for Proton Therapy Market by CNS (Million US$), 2015 – 2025
Figure 5 3: Japan – Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 – 2018
Figure 5 4: Japan – Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2019 – 2025
Figure 5 5: Japan – Proton Therapy Market by Lung Cancer (Million US$), 2009 – 2018
Figure 5 6: Japan – Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2019 – 2025
Figure 5 7: Japan – Proton Therapy Market by GI Cancer (Million US$), 2009 – 2018
Figure 5 8: Japan – Forecast for Proton Therapy Market by GI Cancer (Million US$), 2019 – 2025
Figure 5 9: Japan – Proton Therapy Market by HCC (Million US$), 2009 – 2018
Figure 5 10: Japan – Forecast for Proton Therapy Market by HCC (Million US$), 2019 – 2025
Figure 5 11: Japan – Proton Therapy Market by Pancreas (Million US$), 2009 – 2018
Figure 5 12: Japan – Forecast for Proton Therapy Market by Pancreas (Million US$), 2019 – 2025
Figure 5 13: Japan – Proton Therapy Market by Gynecologic cancers (Million US$), 2009 – 2018
Figure 5 14: Japan – Forecast for Proton Therapy Market by Gynecologic cancers (Million US$), 2019 – 2025
Figure 5 15: Japan – Proton Therapy Market by Prostate cancers (Million US$), 2009 – 2018
Figure 5 16: Japan – Forecast for Proton Therapy Market by Prostate cancers (Million US$), 2019 – 2025
Figure 5 17: Japan – Proton Therapy Market by Bone and Soft Tissue (Million US$), 2009 – 2018
Figure 5 18: Japan – Forecast for Proton Therapy Market by Bone and Soft Tissue (Million US$), 2019 – 2025
Figure 5 19: Japan – Proton Therapy Market by Others (Million US$), 2009 – 2018
Figure 5 20: Japan – Forecast for Proton Therapy Market by Others (Million US$), 2019 – 2025
Figure 10 1: Global – IBA Proton Therapy Sales (Million USD), 2014 – 2018
Figure 10 2: Global – Forecast for IBA Proton Therapy Sales (Million USD), 2019 – 2025
Figure 10 3: Global – Varian Medical Systems Oncology Systems Sales (Million USD), 2014 – 2018
Figure 10 4: Global – Forecast for Varian Medical Systems Oncology Systems Sales (Million USD), 2019 – 2025
Figure 10 5: Global – Elekta Revenue, (Million USD), 2014 – 2018
Figure 10 6: Global – Forecast for Elekta Revenue (Million USD), 2019 – 2025
Figure 11 1: Japan – Number of Patient Diagnosed With Cancer (Thousand), 2014 – 2018
Figure 11 2: Japan – Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2019 – 2025

 

List of Tables




Table 6 1: Japan – Proton Therapy Centers in Operation
Table 6 2: Japan – Proton Therapy Centers in Under-Construction
Table 7 1: Japan – Kashiwa (NCC) Proton Therapy Center with Patients Treated (Number), 2008 – 2016
Table 7 2: Japan – Hyogo (HIBMC) Proton Therapy Center with Patients Treated (Number), 2008 – 2016
Table 7 3: Japan – Tsukuba (PMRC, 2) Proton Therapy Center with Patients Treated (Number), 2008 – 2016
Table 7 4: Japan – WERC Proton Therapy Center with Patients Treated (Number), 2008 - 2009
Table 7 5: Japan – Shizuoka Proton Therapy Center with Patients Treated (Number), 2008 – 2016
Table 7 6: Japan – Koriyama-City Proton Therapy Center with Patients Treated (Number), 2011 - 2016
Table 7 7: Japan – Ibusuki (MMRI) Proton Therapy Center with Patients Treated (Number), 2011 - 2016
Table 7 8: Japan – Fukui City (Prefectural Hospital) Proton Therapy Center with Patients Treated (Number), 2013 - 2015
Table 7 9: Japan – Nagoya PTC, Nagoya, Aichi Proton Therapy Center with Patients Treated (Number), 2013 – 2016
Table 7 10: Japan – Tosu (Saga-HIMAT) Proton Therapy Center with Patients Treated (Number), 2013
Table 7 11: Japan – Nagano Proton Therapy Center with Patients Treated (Number), 2014 - 2016